BXCL501 80 Micrograms
BXCL501-105
Phase 1 small_molecule active
Quick answer
BXCL501 80 Micrograms for Schizophrenia is a Phase 1 program (small_molecule) at BioXcel Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BioXcel Therapeutics
- Indication
- Schizophrenia
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active